Silk Road Medical (SILK)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	22.63 mm	22.63 mm	22.63 mm	22.63 mm	22.63 mm	22.63 mm
Cash burn (monthly)	(no burn)	2.33 mm	4.98 mm	4.77 mm	5.11 mm	2.93 mm
Cash used (since last report)	n/a	20.42 mm	43.64 mm	41.85 mm	44.77 mm	25.71 mm
Cash remaining	n/a	2.21 mm	-21.01 mm	-19.22 mm	-22.14 mm	-3.08 mm
Runway (months of cash)	n/a	0.9	-4.2	-4.0	-4.3	-1.0

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

SILK institutional ownership history Ownership history

52.9% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	100	138	-27.5%
Opened positions	52	120	-56.7%
Closed positions	90	2	+4400.0%
Increased positions	22	5	+340.0%
Reduced positions	16	4	+300.0%

13F shares	Current	Prev Q	Change
Total value	473.17 bn	645.19 bn	-26.7%
Total shares	20.60 mm	37.76 mm	-45.5%
Total puts	205.00 k	132.00 k	+55.3%
Total calls	193.50 k	329.80 k	-41.3%
Total put/call ratio	1.1	0.4	+164.7%

Largest owners	Shares	Value	Change
Bamco	1.28 mm	$34.59 bn	-14.7%
D. E. Shaw & Co.	1.15 mm	$31.23 bn	NEW
STT State Street	1.07 mm	$28.99 bn	+3.3%
WP X Finance	1.02 mm	$44.20 mm	0.0%
Capital World Investors	969.50 k	$26.22 mm	-68.8%
BLVGF Bellevue	855.29 k	$23.13 bn	-43.7%
ArrowMark Colorado	806.82 k	$21.82 bn	NEW
Balyasny Asset Management	780.18 k	$21.10 bn	NEW
Highland Capital Management Fund Advisors	768.25 k	$20.77 bn	NEW
Kennedy Capital Management	748.89 k	$20.25 bn	-27.7%

Largest transactions	Shares	Bought/sold	Change
Wasatch Advisors	262.65 k	-4.29 mm	-94.2%
BLK BlackRock	0.00	-2.97 mm	EXIT
Vanguard	0.00	-2.92 mm	EXIT
Capital World Investors	969.50 k	-2.14 mm	-68.8%
MS Morgan Stanley	312.80 k	-1.52 mm	-82.9%
Sofinnova Investments	0.00	-1.19 mm	EXIT
D. E. Shaw & Co.	1.15 mm	+1.15 mm	NEW
Tri Locum Partners	0.00	-1.08 mm	EXIT
Armistice Capital	0.00	-956.00 k	EXIT
Geode Capital Management	0.00	-877.85 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SILK insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
17 Sep 24	Chas McKhann	Common Stock	Sale back to company	Dispose D	No	No	0	1,299,042	0.00	0
17 Sep 24	Chas McKhann	Common Stock	Grant	Acquire A	No	No	0	1,299,042	0.00	1,299,042
17 Sep 24	Chas McKhann	Common Stock	Sale back to company	Dispose D	No	No	0	722,396	0.00	0
17 Sep 24	Buchanan Lucas W.	Common Stock	Sale back to company	Dispose D	Yes	No	0	13,518	0.00	0
17 Sep 24	Buchanan Lucas W.	Common Stock	Sale back to company	Dispose D	No	No	0	50,876	0.00	0
17 Sep 24	Buchanan Lucas W.	Common Stock	Grant	Acquire A	No	No	0	50,876	0.00	50,876
17 Sep 24	Buchanan Lucas W.	Common Stock	Sale back to company	Dispose D	No	No	0	503,295	0.00	0
17 Sep 24	Buchanan Lucas W.	Employee Stock Option Common Stock	Sale back to company	Dispose D	No	No	7.5	5,331	39.98 k	0
17 Sep 24	Lasersohn Jack W	Common Stock	Sale back to company	Dispose D	No	No	0	16,735	0.00	0
17 Sep 24	Lasersohn Jack W	Stock Option Common Stock	Sale back to company	Dispose D	No	No	7.5	8,910	66.83 k	0

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Boston Scientific Announces Results for Third Quarter 2024

23 Oct 24

MARLBOROUGH, Mass., Oct. 23, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.209 billion during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent